For the year ending 2025-12-31, BHC had $124M increase in cash & cash equivalents over the period. $1,003M in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 120 |
| Depreciation and amortization of intangible assets | 1,208 |
| Amortization and write-off of debt discounts and debt issuance costs | 94 |
| Asset impairments | 8 |
| Goodwill impairment | 145 |
| Acquisition-related contingent consideration | -36 |
| Allowances for losses on trade receivables and inventories | 71 |
| Deferred income taxes | 80 |
| Net gain on sale of assets | 6 |
| Additions to accrued legal settlements | -61 |
| Payments of accrued legal settlements | 215 |
| Share-based compensation | 216 |
| Gain excluded from hedge effectiveness | 10 |
| Gain on extinguishment of debt | 162 |
| Third party fees paid in connection with the 2022 exchange | 0 |
| Payments of contingent consideration adjustments, including accretion | 8 |
| Amortization of inventory step-up resulting from acquisitions | 64 |
| Foreign exchange and other | 11 |
| Trade receivables | 134 |
| Inventories | 12 |
| Prepaid expenses and other current assets | -3 |
| Accounts payable, accrued and other liabilities | -76 |
| Net cash provided by operating activities | 1,400 |
| Acquisitions and other investments | 204 |
| Purchases of property, plant and equipment | 397 |
| Acquisition of intangible assets and other assets | 10 |
| Purchases of marketable securities | 11 |
| Proceeds from sale of marketable securities | 8 |
| Proceeds from sale of assets and businesses, net of costs to sell | 7 |
| Interest settlements from cross-currency swaps | -12 |
| Net cash used in investing activities | -595 |
| Issuance of long-term debt, net of discounts | 10,554 |
| Repayments of long-term debt | 11,191 |
| Payment of employee withholding taxes related to share-based awards | 24 |
| Payments of acquisition-related contingent consideration | 26 |
| Payments of financing costs | 45 |
| Other | -10 |
| Net cash (used in) provided by financing activities | -742 |
| Effect of exchange rate changes on cash and cash equivalents | 61 |
| Net increase in cash, cash equivalents and restricted cash | 124 |
Bausch Health Companies Inc. (BHC)
Bausch Health Companies Inc. (BHC)